Ropes Wealth Advisors’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-2,350
| Closed | -$278K | – | 303 |
|
|
2021
Q4 | $278K | Hold |
2,350
| – | – | 0.05% | 229 |
|
|
2021
Q3 | $315K | Hold |
2,350
| – | – | 0.05% | 223 |
|
|
2021
Q2 | $380K | Buy |
+2,350
| New | +$380K | 0.06% | 200 |
|
|
2021
Q1 | – | Sell |
-2,350
| Closed | -$128K | – | 598 |
|
|
2020
Q4 | $128K | Buy |
2,350
+2,000
| +571% | +$109K | 0.02% | 281 |
|
|
2020
Q3 | $7K | Hold |
350
| – | – | ﹤0.01% | 544 |
|
|
2020
Q2 | $7K | Hold |
350
| – | – | ﹤0.01% | 473 |
|
|
2020
Q1 | $4K | Hold |
350
| – | – | ﹤0.01% | 468 |
|
|
2019
Q4 | $5K | Hold |
350
| – | – | ﹤0.01% | 500 |
|
|
2019
Q3 | $5K | Sell |
350
-1,000
| -74% | -$14.3K | ﹤0.01% | 514 |
|
|
2019
Q2 | $22K | Buy |
1,350
+1,000
| +286% | +$16.3K | ﹤0.01% | 422 |
|
|
2019
Q1 | $6K | Buy |
+350
| New | +$6K | ﹤0.01% | 474 |
|